COG — Cambridge Cognition Holdings Share News
0.000.00%
- £15.10m
- £14.02m
- £13.52m
- 15
- 20
- 65
- 21
REG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Acquisition of Winterlight Labs Inc
AnnouncementREG - Cambridge Cognition - Strategic Partnership for Chinese Market Expansion
AnnouncementREG - Cambridge Cognition - £1.1 million eCOA contract win
AnnouncementREG - Cambridge Cognition - Acquisition of eClinicalHealth Limited
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementREG - Cambridge Cognition - £2.2m neurodegenerative disease trial contract
AnnouncementRCS - Cambridge Cognition - Alzheimer’s Disease Validation for NeuroVocalix
AnnouncementREG - Cambridge Cognition - Directorate Change
AnnouncementREG - Cambridge Cognition - PTSD trials with top 10 pharma company & US DoD
AnnouncementREG - Cambridge Cognition - Grant of Options
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Trading Update and Notice of Results
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
Announcement